- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05241080
Stress Among Final Year BAMS Students in Relation With Covid Lockdown Through CSSQ-a Cross Sectional Survey
February 14, 2022 updated by: Dr.Preethi Mohan, Amrita Vishwa Vidyapeetham
Covid -19 Related Stress Among Final Year BAMS Students During Lock Down Days in Kerala-A Cross Sectional Study
We were randomly selected the ayurveda colleges in Kerala.Selected final year BAMS students as participants.we
have also selected a group of 5 members for data colle tion.we
have selected a validated Covid stress questionnaire and circulated through what's app and Gmail.we were received responses from each college with .we
analyzed and interpreted data.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We were randomly selected the ayurveda colleges in Kerala.Selected final year BAMS students as participants.we
have also selected a group of 5 members for data colle tion.we
have selected a validated Covid stress questionnaire and circulated through what's app and Gmail.we were received responses from each college with .we
analyzed and interpreted data.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kerala
-
Kollam, Kerala, India, 690525
- Dr Preeti
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 22 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All final year students Of BAMS studying inside Kerala.
Description
Inclusion Criteria 1.final year BAMS 2.irrespective of gender
-
Exclusion Criteria:
- age group other than 20-22 yrs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Likert scale
Time Frame: 10 days
|
4 point likert scale questionnaire
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dr.preethi Mohan, BAMS MD, Amrita Viswa Vidyapeetham
- Principal Investigator: Delvin T Robin, Amrita Vishwa Vidyapeetham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2021
Primary Completion (Actual)
December 10, 2021
Study Completion (Actual)
December 10, 2021
Study Registration Dates
First Submitted
February 14, 2022
First Submitted That Met QC Criteria
February 14, 2022
First Posted (Actual)
February 15, 2022
Study Record Updates
Last Update Posted (Actual)
February 15, 2022
Last Update Submitted That Met QC Criteria
February 14, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Not yet assaigned
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.